Skip to Main content Skip to Navigation
Conference papers

Acute effects of lixisenatide on intragastric meal distribution: impact on energy intake

Abstract : Background and aims: Glucagon-like peptide-1 agonists (GLP-1RAs) induce weight loss in obese patients and, particularly with ‘short-acting’ GLP-1RAs, slow gastric emptying (GE). In healthy subjects, energy intake after a nutrient ‘preload’ is more strongly related to the content of the distal, than the total, stomach. The effect of GLP-1RAs on intragastric meal distribution has not been reported.We evaluated the acute effects of lixisenatide (LIXI) on intragastric distribution of a glucose drink and subsequent energy intake in health and type 2 diabetes (T2DM). Materials and methods: 15 healthy subjects (9M, 6F; age: 67.2 ± 2.3 yr; BMI: 25.4 ± 0.8 kg/m2) and 15 T2DMpatients managed by diet ormetformin (9M, 6F; age: 61.9 ± 2.3 yr; BMI: 30.3 ± 0.7 kg/m2; duration of known diabetes: 5.3 ± 1.2 yr; HbA1c: 6.9 ± 0.2%were studied. All subjects received LIXI (10mcg sc) or placebo (PLAC) on 2 separate days in a randomised, double-blind, crossover fashion 30 min before a 75g glucose drink labelled with 20MBq 99mTc-Calcium Phytate. A lower than usual dose of LIXI was used to maximise tolerability. GE was measured by scintigraphy for 180 min. A region-of-interest was drawn around the total stomach, which was divided into proximal and distal stomach regions. At 180 min each participant was offered a buffet meal and allowed to eat for 30 min to assess subsequent energy intake. Nausea was measured, using a visual analogue questionnaire, prior to receiving study drug, before the drink and at regular intervals during the study. Data are mean ± SEM and P<0.05 was considered significant. Results: The studies were well tolerated; scores for nausea were uniformly lowwith no difference between PLAC and LIXI in either group. LIXI slowed GE (% total stomach retention at 180 min - health: PLAC 16.0 ± 11.1 vs LIXI 59.5 ± 24.6 ; T2DM: PLAC 14.5 ± 7.5 vs LIXI 54.4 ± 27.5) and increased retention in both the proximal stomach (health: PLAC 6.6 ± 3.5 vs LIXI 40.9 ± 24.6 ; T2DM: PLAC 6.3 ± 4.1 vs LIXI 34.8 ± 24.5) and distal stomach (health: PLAC 9.4 ± 9.1 vs LIXI 18.6 ± 11.1 ; T2DM: PLAC 8.2 ± 4.2 vs LIXI 19.6 ± 10.4); P<0.001 for PLAC vs LIXI in all groups. LIXI decreased energy intake (P<0.001) in both health and T2DM (Figure). Energy intake was inversely related to the distal stomach content at 180 min in health on PLAC (r=-0.58, P=0.03), but not in T2DM (r=-0.31, P=0.27), nor after LIXI (health: r=-0.16, P=0.58 vs T2DM: r=-0.004, P=0.99). Conclusion: In healthy subjects and T2DM patients, LIXI (10mcg) decreases energy intake in the absence of nausea, slows GE and increases retention in the distal and proximal stomach. The acute reduction in energy intake by LIXI is unrelated to changes in GE/intragastric distribution, consistent with a centrally-mediated effect.
Document type :
Conference papers
Complete list of metadata
Contributor : Migration Prodinra Connect in order to contact the contributor
Submitted on : Tuesday, June 2, 2020 - 1:42:39 PM
Last modification on : Tuesday, September 7, 2021 - 3:36:25 PM


  • HAL Id : hal-02734334, version 1
  • PRODINRA : 485718
  • WOS : 000485303800150



R.J. Jalleh, H.T. Pham, C.S. Marathe, T. Wu, M.D. Buttfield, et al.. Acute effects of lixisenatide on intragastric meal distribution: impact on energy intake. 55. Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), Sep 2019, Barcelone, Spain. ⟨hal-02734334⟩



Les métriques sont temporairement indisponibles